Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. Tissueengineered skin plays an important role in wound care focusing on strategies such autologous dermal-epidermal substitutes. Objective: The aim of this study was to obtain autologous dermal-epidermal skin substitutes from oral application for cases of diabetic foot. Material and Methods: Oral mucosa was obtained from diabetic and healthy subjects (n=20 per group). Epidermal epidermal in vitro substitutes by the air-liquid technique with autologous human serum as a supplement media. Substitutes were immunocharacterized was performed to assess the differences between both groups. Results: It was possible to isolate epidermal cells from the oral mucosa of diabetic and healthy subjects and develop autologous dermal-epidermal skin substitutes using autologous serum as a supplement. Differences in the expression was lower in the diabetic substitutes, and the collagen IV expression was higher in the diabetic substitutes when compared with the healthy group, be an alternative and less invasive source for skin substitutes and wound healing. A difference in collagen production of diabetic cells suggests diabetic substitutes could improve diabetic wound healing. More research is needed to determine the crosstalk between components of these skin substitutes and damaged tissues.
. This tissue also has the advantage that its harvesting produces less disability, and provides better aesthetic outcomes.
With these special features, it is assumed that the skin substitute obtained from oral mucosa can be produced faster. A possible disadvantage for the use of oral mucosa as an epidermal cell source could be the differentiation of the epithelial pattern of keratinocytes from oral mucosa, which differs from that of epidermal keratinocytes and skin. The skin is an example of an orthokeratinized epithelium. It displays a stratum basale, stratum spinosum, stratum granulosum and stratum corneum. Gingiva tissue also consists of an epithelium on a connective tissue matrix populated in contrast to skin, the epithelium is parakeratinized 27 .
In this regard, Ueda, et al. 26 (1995) Cell cultures characterization part of the cell cultures were used for an indirect characterization of these cell cultures was performed.
was anti-collagen I (Santa Cruz Biotechnology, Paso
Robles, CA, USA) mainly because due to its abundance in the skin, recognized as the most abundant collagen Obtaining and characterization of cell cultures 
Cell growth curve
Cell proliferation results showed a significant increased growth in the diabetic group at time 0 vs 3 days (p=0.009), and time 0 vs 9 days (p=0.004); 
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showed, indicating greater variability in the behavior of the diabetic group compared with the healthy group ( Figure 3 , Table 2 ).
Development of the dermo-epidermal substitute
Substitutes were developed using the air-liquid technique, as previously described. The culture time for the stromal and epithelial phase was 10 days for each. Once both phases were completed, diabetic and healthy substitutes were observed with an inverted microscope at 40X, showing interesting features.
observed in the diabetic substitutes, whereas healthy substitutes showed a globular pattern with fewer substitutes was clear and humid with an adherence to surfaces ( Figure 5 ).
Dermal-epidermal substitute evaluation and characterization
Each substitute was characterized and assessed as previously described. Anti-cytokeratin 5-14 expression showed 1.14 AFU) less in the diabetic substitutes compared with the healthy control group. Anti-collagen IV expression was 1.9 AFU higher in the diabetic substitutes when compared with the healthy group. In addition, dermo-epidermal skin substitutes were immunostained with Sytox Red . It is important to point out that for the clinical application of these skin dermal-epidermal substitutes, cell culture times should be reduced, and thereby the enzymatic digestion technique is a good strategy to be used for future studies.
Regarding the development of dermo-epidermal culture technique for obtaining these skin equivalents. Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects 2 (NTR2), whereas expression levels of neurotensin Also it is necessary to emphasize that the cells not only survived through the development process of the substitute, but also they were integrated in to the dermal matrix and secreted basal membrane markers CK5-14 and COL IV.
is not yet known, further studies are needed to elucidate them. However this data may provide a basis to perfect/improve the development technique of the dermal-epidermal substitutes from the oral mucosa of diabetic patients and to answer the biological questions raised by it.
Within the constraints of our study, it is worth mentioning that no in vitro tests were performed to evaluate the functionality of the developed substitute, such as migration essays. In that matter, the next step would be in vivo and in vitro essays of functionality of these substitutes developed by this technique and the characterization proposed in this study. This will lead us to the future clinical application of these diabetic skin substitutes.
Conclusions
It is possible to develop dermal-epidermal substitutes from the isolation of the epidermal cells of oral mucosa from diabetic and healthy subjects using the air-liquid technique and its assessment by D e r m a l -e p i d e r m a l s k i n s u b s t i t u t e s o f diabetic subjects showed reduced keratinocyte GUZMÁN-URIBE D, ALVARADO-ESTRADA KN, PIERDANT-PÉREZ M, TORRES-ÁLVAREZ B, SÁNCHEZ-AGUILAR JM, ROSALES-IBÁÑEZ R the substitutes from healthy subjects; while for showed a greater intensity, with a higher AFU value.
under this clinical condition; however more research is needed to determine the crosstalk which occurs between the components of these skin substitutes and the damaged tissues. The following long-term goal in this research is the clinical application of these substitutes; further in vivo animal studies to evaluate functionality will be performed to continue with this matter.
